Genital Warts Treatment Market

Fastest growing segment fueling the growth of Genital Warts Treatment Market

by

The global Genital Warts Treatment Market is estimated to be valued at US$ 1785.61 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Genital warts, also known as condylomata acuminata, are the most commonly diagnosed sexually transmitted disease worldwide. They are transmitted through skin-to-skin contact usually during vaginal, anal or oral sex. Genital warts can appear in the genital area, including the vulva, vagina, penis, scrotum and anus.

Market Overview: –

Genital warts are caused by low-risk human papillomaviruses – HPV types 6 and 11. The most common treatments for genital warts include cryotherapy, electrosurgery, excision and topical treatments like creams and ointments. These therapies destroy the visible genital warts, however, there is a chance of reoccurrence.

Market key trends: –

One of the key trends in the genital warts treatment market is development of therapeutic vaccines to prevent genital warts and HPV infection. Scientists are developing the next generation of prophylactic vaccines that if successful can help reduce the incidence of genital warts.

Segment Analysis: –

The global genital warts treatment market is segmented into therapeutic class, treatment type, end-use, and distribution channel. Based on therapeutic class, the immunomodulators segment is expected to dominate the market over the forecast period. Immunomodulators are more effective in clearing genital warts and have fewer side effects as compared to other treatment options like topical therapies.

Key Takeaways: –

The Global Genital Warts Treatment Market Growth is expected to witness high, exhibiting a CAGR of 4.7% over the forecast period, due to the increasing prevalence of human papillomavirus (HPV) infection.

Regional Analysis: –

North America is expected to dominate the global genital warts treatment market over the forecast period owing to the rising incidences of HPV and presence of advanced healthcare facilities in the region. Asia Pacific region is anticipated to exhibit the fastest growth during the forecast period credited to growth in research funding, rising awareness regarding sexually transmitted diseases, and developing healthcare infrastructure.

Key Players: –

Key players operating in the genital warts treatment market are Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee’s Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG.

*Note:
1.  Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

Ravina
+ posts

Ravina Pandya,  Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.